According to Bloomberg, U.S. District Judge Brian Martinotti in New Jersey will allow a proposed class-action suit to proceed against Eli Lilly & Company, Novo Nordisk A/S, and Sanofi, a French drug manufacturer who has a unit in the U.S. The lawsuit, filed by 67 diabetics, accuses the companies of inflating prices.